A general term referring to lyophilized (freeze-dried) peptide compounds that require the addition of a sterile solvent, typically bacteriostatic water, to return them to a liquid, injectable, or administrable form. This process of reconstitution is a critical step in the clinical and research application of many peptide therapeutics to ensure their stability and biological activity. Proper technique is essential to maintain the integrity of the fragile amino acid chain and ensure sterile preparation.
Origin
This term is a procedural and pharmaceutical classification, stemming from the need for long-term storage of biologically active, yet chemically unstable, peptide molecules. Lyophilization removes water, preventing degradation, and reconstitution is the necessary step to prepare the compound for use. The process is a standard technique in modern pharmaceutical chemistry for preserving delicate biological agents.
Mechanism
The mechanism involves the solvent, bacteriostatic water, breaking the intermolecular forces that hold the dry powder together, allowing the peptide molecules to disperse and return to their native, biologically active three-dimensional structure in solution. The bacteriostatic agent, usually benzyl alcohol, is included to inhibit microbial growth, ensuring the sterility of the solution for the duration of its clinical use and preventing potential infection.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.